MSB 1.95% $1.05 mesoblast limited

Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-32

  1. 6,418 Posts.
    lightbulb Created with Sketch. 2615
    Guys; just so no one is confused, this is not the big one. This is lining up the ducks for fast FDA approval of both the Emergency Use Approval (EUA) and full FDA approval of Rem-L for C-19 ARDS. Major positive signal and no doubt will be a good day for the SP. But given the short position, it could be a great day for the SP.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.05
Change
0.020(1.95%)
Mkt cap ! $1.193B
Open High Low Value Volume
$1.02 $1.07 $1.02 $7.487M 7.196M

Buyers (Bids)

No. Vol. Price($)
4 39700 $1.05
 

Sellers (Offers)

Price($) Vol. No.
$1.05 86509 6
View Market Depth
Last trade - 16.10pm 07/06/2024 (20 minute delay) ?
Last
$1.05
  Change
0.020 ( 1.89 %)
Open High Low Volume
$1.02 $1.07 $1.02 1379563
Last updated 15.59pm 07/06/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.